{"id":162600,"date":"2024-02-16T15:37:56","date_gmt":"2024-02-16T10:07:56","guid":{"rendered":"https:\/\/www.gkseries.com\/blog\/?p=162600"},"modified":"2024-02-16T15:37:56","modified_gmt":"2024-02-16T10:07:56","slug":"aiims-launches-ioncology-ai-for-early-cancer-detection","status":"publish","type":"post","link":"https:\/\/www.gkseries.com\/blog\/aiims-launches-ioncology-ai-for-early-cancer-detection\/","title":{"rendered":"AIIMS Launches iOncology.ai for Early Cancer Detection"},"content":{"rendered":"\n<p>In a landmark collaboration between AIIMS, New Delhi, and the Centre for Development of Advanced Computing (CDAC), Pune, the groundbreaking&nbsp;<strong>AI platform iOncology.ai<\/strong>&nbsp;has been unveiled. This cutting-edge technology focuses on the early detection of cancer, particularly targeting breast and ovarian cancers, which are prevalent among women in India.<\/p>\n<p>Global Cancer Scenario<\/p>\n<ul>\n<li>Cancer surpasses cardiovascular diseases in high-income and middle-income countries in terms of fatality rates.<\/li>\n<li>GLOBOCAN estimates for 2020 show 19.3 million incident cancer cases worldwide, with India ranking third after China and the United States.<\/li>\n<\/ul>\n<p>Cancer Statistics in India<\/p>\n<ul>\n<li>A Lancet study predicts a 57.5% increase in cancer cases in India by 2040, reaching 2.08 million.<\/li>\n<li>In 2022, over 8 lakh deaths in India were attributed to cancer, mainly due to late detection, resulting in a mere 20% survival rate.<\/li>\n<\/ul>\n<p>About iOncology.ai<\/p>\n<ul>\n<li>Developed in collaboration with CDAC and the Ministry of Electronics &amp; Information Technology, iOncology.ai utilizes AI to reduce false negatives in manual cancer diagnosis.<\/li>\n<li>The platform employs deep learning models and self-learning capabilities to analyze complex medical data with unparalleled accuracy and efficiency.<\/li>\n<li>Initial focus lies on early detection of breast and ovarian cancers, leveraging a dataset of approximately half a million radiological and histopathological images from AIIMS.<\/li>\n<\/ul>\n<p>Positive Reception and Future Collaborations<\/p>\n<ul>\n<li>iOncology.ai has been successfully implemented in five district hospitals, demonstrating its potential for widespread impact.<\/li>\n<li>It received positive feedback at a Med-Hackathon event during AIIMS Research Day celebrations and is poised for further partnerships with cancer hospitals and research centers across India.<\/li>\n<\/ul>\n<p>MoU between AIIMS and DGE for Rheumatological Disorders<\/p>\n<ul>\n<li>The Department of Rheumatology at AIIMS New Delhi has signed an MoU with the Directorate General of Employment, Ministry of Labour &amp; Employment, Government of India.<\/li>\n<li>This initiative aims to address challenges faced by patients with disabilities due to rheumatological disorders by providing certifications for employable skills and promoting economic upliftment and vocational rehabilitation.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a landmark collaboration between AIIMS, New Delhi, and the Centre for Development of Advanced Computing (CDAC), Pune, the groundbreaking&nbsp;AI platform iOncology.ai&nbsp;has been unveiled. This cutting-edge technology focuses on the early detection of cancer, particularly targeting breast and ovarian cancers, which are prevalent among women in India. Global Cancer Scenario Cancer surpasses cardiovascular diseases in [&hellip;]<\/p>\n","protected":false},"author":419,"featured_media":162601,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5231],"tags":[1475,68],"offerexpiration":[],"class_list":["post-162600","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-current-affairs-february-2024","tag-daily-current-affairs","tag-science-technology-current-affairs"],"_links":{"self":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/162600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/users\/419"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/comments?post=162600"}],"version-history":[{"count":1,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/162600\/revisions"}],"predecessor-version":[{"id":162602,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/162600\/revisions\/162602"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/media\/162601"}],"wp:attachment":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/media?parent=162600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/categories?post=162600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/tags?post=162600"},{"taxonomy":"offerexpiration","embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/offerexpiration?post=162600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}